GILEAD SCIENCES, INC.

Q2 2026 13F-HR Holdings

Location
Foster City, CA
Holdings as of
6/30/2026
Date filed
8/3/2026
Form type
13F-HR
Num holdings
5
Total value ($000)
$1,648,748
Net value change ($000)
-469,037 (-22.1%)
New positions
0
Sold out positions
1
Turnover %
46.8%
Sector allocation + QoQ delta (equities-only)

Holdings aggregated across other managers listed in the original SEC filing. View detailed breakdown

Prev filing: 5/8/2026 Next filing: — SEC filing

Snapshot: Change Analysis

Compared to Q1 2026
Methodology: sector metrics are equities-only; instrument mix chart is ex-options; options exposure is shown separately. Why this matters.
Top Adds (Value $000, Stocks/ETFs)
RCUS 290,050 42.7%
ASMB 11,745 9.4%
KYTX 1,156 3.2%
XLO 761 13.9%
Top Reduces (Value $000, Stocks/ETFs)
ACLX -771,683 -100.0%
GLPG -1,066 -0.2%
Instrument mix + QoQ Δ (ex-options)
How this table is calculated: SEC VALUE ($000) is used as reported. For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received. Column % is bucket-based: non-options share is calculated inside non-option total, options share is calculated inside options total. Details.
Filter:
Instrument:
Issuer Name Ticker Sector Industry Class History Value ($000) % Shares Shares Δ Shares Δ% Value Δ ($000) Value Δ% Principal Option Type